stockportfolio.pro
Moderna, Inc. Revenue 2016–2025
Moderna, Inc. (MRNA) annual revenue by fiscal year, computed from SEC filings. Compound growth +37.8%/yr over 9 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $1.94B | -39.9% |
| FY 2024 | $3.24B | -52.7% |
| FY 2023 | $6.85B | -64.4% |
| FY 2022 | $19.26B | +4.3% |
| FY 2021 | $18.47B | +2200.2% |
| FY 2020 | $803.00M | +1238.3% |
| FY 2019 | $60.00M | -55.6% |
| FY 2018 | $135.07M | -34.4% |
| FY 2017 | $205.82M | +89.9% |
| FY 2016 | $108.40M | — |
Source: Moderna, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Moderna, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeModerna, Inc. — frequently asked questions
What is Moderna, Inc.'s revenue?
Moderna, Inc. (MRNA) reported revenue of $1.94B for fiscal year 2025, per its SEC filings.
How has Moderna, Inc.'s revenue changed over time?
Between fiscal 2016 and 2025, MRNA's revenue grew at roughly 37.8% per year (compound annual rate), from $108.40M to $1.94B.
Where does this data come from?
Figures are computed from Moderna, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.